Page last updated: 2024-08-16

canrenoic acid and Atrial Fibrillation

canrenoic acid has been researched along with Atrial Fibrillation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dąbrowski, R; Farkowski, M; Hryniewiecki, T; Kowalik, I; Kubaszek-Kornatowska, A; Mączyńska, J; Michałek, P; Sawicki, S; Syska, P; Szwed, H	1

Trials

1 trial(s) available for canrenoic acid and Atrial Fibrillation

Article	Year
Clinical efficacy of potassium canreonate-canrenone in sinus rhythm restoration among patients with atrial fibrillation - a protocol of a pilot, randomized, double -blind, placebo-controlled study (CANREN-AF trial). Trials, 2020, May-12, Volume: 21, Issue:1 Topics: Administration, Intravenous; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Canrenoic Acid; Case-Control Studies; Double-Blind Method; Electric Countershock; Electrocardiography; Heart Failure; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Placebos; Potassium; Renin-Angiotensin System; Safety; Sinoatrial Node; Treatment Outcome	2020

Article

Year

Clinical efficacy of potassium canreonate-canrenone in sinus rhythm restoration among patients with atrial fibrillation - a protocol of a pilot, randomized, double -blind, placebo-controlled study (CANREN-AF trial).

Trials, 2020, May-12, Volume: 21, Issue:1

Topics: Administration, Intravenous; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Canrenoic Acid; Case-Control Studies; Double-Blind Method; Electric Countershock; Electrocardiography; Heart Failure; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Placebos; Potassium; Renin-Angiotensin System; Safety; Sinoatrial Node; Treatment Outcome

2020